|
⚲
|
| Keyboard |
| Katkin Keith
✚
|
|
|---|---|
| CIK # | 0001314596 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001314596] | |
| 4 | [0001314596] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2026-02-04 | Grant | 24,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Common Stock
|
2026-01-10 | Option exercise | 8,575 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
|
2026-01-10 | Option exercise | 8,575 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2025-05-23 | Sell | 7,844 | $6.30 | 49,417 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-05-19 | Buy | 10,000 | $9.11 | 91,100 |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2025-04-30 | Grant | 34,403 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Stock Option (Right to Buy) · derivative
|
2025-04-30 | Grant | 15,824 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-05 | Grant | 25,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
|
2025-01-10 | Grant | 8,575 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2025-01-10 | Grant | 77,175 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 25,748 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2024-05-23 | Grant | 17,430 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2024-02-07 | Grant | 17,000 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2023-05-25 | Grant | 33,847 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2023-05-01 | Grant | 752,185 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2023-02-02 | Grant | 16,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2023-02-01 | Grant | 20,000 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2022-10-06 | Option exercise | 9,117 | $8.93 | 81,415 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2022-10-06 | Sell | 20,782 | $25.90 | 538,254 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2022-10-06 | Sell | 9,117 | $25.90 | 236,130 |
| showing 20 of 107 most recent transactions | |||||